A comprehensive view of Capsules / Pills / Tablets. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Pet Care Market Intelligence Service.
The FDA approves ViiV Healthcare’s Dovato (dolutegravir/lamivudine) for adolescents aged 12 and above for the treatment of HIV-1 infection; Dovato offers a single-tablet, two-drug oral regimen for HIV therapy
Published:
April 08, 2024
by GSK Group (GlaxoSmithKline)
|
Evonik highlights its EUDRAGIT brand of polymers as key ingredients in coating systems for pharmaceuticals; company introduces EUDRACAP, an option for enteric capsule production
Published:
April 04, 2024
by Evonik Industries AG
|
Upsher-Smith Laboratories launches Methimazole tablets, USP, 5 mg and 10 mg., in the US with potential market value of US$36.8M; original reference is Pfizer's brand Tapazole
Published:
April 01, 2024
by M2 Pharma
|
Kobayashi Pharmaceutical's red yeast rice cholesterol-lowering supplement linked to five deaths due to kidney disease, prompting voluntary product recall and extensive investigations; over 100 people hospitalized after consuming the product
Published:
March 29, 2024
by CE Noticias Financieras (Latin America)
|
Sun Pharma's US branch recalls 55,272 bottles of febuxostat gout tablets due to microbial contamination at its Dadra, India, manufacturing facility; recall covers 40-milligram and 80-milligram dosages
Published:
March 11, 2024
by FiercePharma
|
Ask us about our Pet Care market view